Researchers are preparing to launch the SA leg of an international trial investigating whether the well-established measles, mumps and rubella (MMR) shot used in childhood immunisation programmes can protect front-line health-care workers from Sars-CoV-2, the virus that causes Covid-19.

More than 170 potential Covid-19 vaccines are being developed worldwide, but only nine are in late-stage phase 3 efficacy trials, and none has yet been approved by regulators, says the World Health Organisation. Researchers are thus also investigating whether tried-and-tested vaccines that provide protection from diseases as diverse as polio, tuberculosis and measles might provide a stopgap measure against Covid-19...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now